2027 AHNS Presidential Award: Integrating Emerging Technologies for Head and Neck Cancer Translational, Clinical, and Epidemiological Research
2027 AHNS Presidential Award supports multidisciplinary researchers using emerging technologies in head and neck cancer research to advance early detection, risk prediction, and treatment response.
Browse similar grants
Funder: American Academy of Otolaryngology - Head and Neck Surgery
Due Dates: December 15, 2026 (Letter of intent) | January 15, 2027 (Full application)
Funding Amounts: Up to $15,000 for 12 months, non-renewable; one award available per year
Summary: Supports emerging-technology research in head and neck cancer to advance early detection, risk prediction, and treatment response.
Key Information: Applicants must reside in the U.S. or Canada and be AHNS members in good standing.
Description
The American Head and Neck Society (AHNS) offers this Presidential Award through the Academy’s CORE grants process to support innovative, multidisciplinary research integrating emerging technologies into translational clinical and epidemiologic studies of head and neck cancer. It aims to close knowledge gaps in early detection, precision prevention, and effective, cost-effective treatment, particularly for patients with locally advanced disease or treatment-related morbidity.
Projects may use single-cell and spatial multi-omics, AI-enabled digital pathology, advanced imaging, wearable or remote monitoring devices, and real-time data integration. These tools should generate insights or practical applications for disease mechanisms, biomarkers, risk prediction, or treatment response. The program encourages patient-centered interventions, disparities-focused research, and collaboration across disciplines, with priority for innovative projects capable of developing into expanded, externally funded research programs.
